TY - JOUR
T1 - Prostate cancer genetic risk and associated aggressive disease in men of African ancestry
AU - Soh, Pamela X.Y.
AU - Mmekwa, Naledi
AU - Petersen, Desiree C.
AU - Gheybi, Kazzem
AU - van Zyl, Smit
AU - Jiang, Jue
AU - Patrick, Sean M.
AU - Campbell, Raymond
AU - Jaratlerdseri, Weerachai
AU - Mutambirwa, Shingai B.A.
AU - Bornman, M. S.Riana
AU - Hayes, Vanessa M.
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - African ancestry is a significant risk factor for prostate cancer and advanced disease. Yet, genetic studies have largely been conducted outside the context of Sub-Saharan Africa, identifying 278 common risk variants contributing to a multiethnic polygenic risk score, with rare variants focused on a panel of roughly 20 pathogenic genes. Based on this knowledge, we are unable to determine polygenic risk or differentiate prostate cancer status interrogating whole genome data for 113 Black South African men. To further assess for potentially functional common and rare variant associations, here we interrogate 247,780 exomic variants for 798 Black South African men using a case versus control or aggressive versus non-aggressive study design. Notable genes of interest include HCP5, RFX6 and H3C1 for risk, and MKI67 and KLF5 for aggressive disease. Our study highlights the need for further inclusion across the African diaspora to establish African-relevant risk models aimed at reducing prostate cancer health disparities.
AB - African ancestry is a significant risk factor for prostate cancer and advanced disease. Yet, genetic studies have largely been conducted outside the context of Sub-Saharan Africa, identifying 278 common risk variants contributing to a multiethnic polygenic risk score, with rare variants focused on a panel of roughly 20 pathogenic genes. Based on this knowledge, we are unable to determine polygenic risk or differentiate prostate cancer status interrogating whole genome data for 113 Black South African men. To further assess for potentially functional common and rare variant associations, here we interrogate 247,780 exomic variants for 798 Black South African men using a case versus control or aggressive versus non-aggressive study design. Notable genes of interest include HCP5, RFX6 and H3C1 for risk, and MKI67 and KLF5 for aggressive disease. Our study highlights the need for further inclusion across the African diaspora to establish African-relevant risk models aimed at reducing prostate cancer health disparities.
UR - http://www.scopus.com/inward/record.url?scp=85178850399&partnerID=8YFLogxK
U2 - 10.1038/s41467-023-43726-w
DO - 10.1038/s41467-023-43726-w
M3 - Article
C2 - 38052806
AN - SCOPUS:85178850399
SN - 2041-1723
VL - 14
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 8037
ER -